Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Cuprous Ions Binding to Cytosine and Guanine Oligonucleotides.

Created on 09 Aug 2026

Authors

Joana Pereira, Mathilde Brachet, Philippe Barthélémy, Bruno Alies

Published in

Chembiochem : a European journal of chemical biology. Volume 27. Issue 15. Pages e70499. Aug 14, 2026.

Abstract

Using a set of spectroscopic experiments, we investigated the binding of Cu2+ and Cu+ to a comprehensive series of nucleic acid-related molecules, ranging from individual nucleobases to oligonucleotides up to six nucleotides in length. We demonstrate the selective binding of Cu+ to cytosine- and guanine-containing oligonucleotides, as evidenced by their ability to compete with ferrozine for Cu+. The capacity to inhibit ascorbate oxidation, through effective sequestration catalytically active copper, increases with the number of cytosine residues in the oligonucleotides and is associated with the formation of a 1:1 Cu+-oligonucleotide complex accompanied by a pronounced conformational change. In contrast, guanine-rich oligonucleotides exhibit the opposite behavior: they form Cu+ G-quadruplex structures that permit copper redox cycling. These findings highlight an unexpected binding of copper ions to nucleic acids in inert or redox-active modes and thus expand its potential roles within cells through its direct interaction with DNA or RNA.

PMID:
42571639
Bibliographic data and abstract were imported from PubMed on 09 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement